Gene: SLC35E1
Official Full Name: solute carrier family 35 member E1provided by HGNC
Gene Summary: Predicted to enable antiporter activity. Predicted to be involved in transmembrane transport. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14025 | SLC35E1 Knockout cell line (HeLa) | Human | SLC35E1 | 1:3~1:6 | Negative | Online Inquiry |
KO14026 | SLC35E1 Knockout cell line (HCT 116) | Human | SLC35E1 | 1:2~1:4 | Negative | Online Inquiry |
KO14027 | SLC35E1 Knockout cell line (HEK293) | Human | SLC35E1 | 1:3~1:6 | Negative | Online Inquiry |
KO14028 | SLC35E1 Knockout cell line (A549) | Human | SLC35E1 | 1:3~1:4 | Negative | Online Inquiry |
SLC35E1 Gene Knockout Cell Lines are advanced biological research tools designed to facilitate in-depth studies of the SLC35E1 gene's role in cellular processes. These engineered cell lines are created through precise genetic manipulation techniques, enabling researchers to effectively deactivate the SLC35E1 gene, thus allowing for the examination of its functions and associated signaling pathways.
The primary mechanism of these knockout cell lines operates through the CRISPR-Cas9 gene-editing technology, which introduces targeted double-strand breaks in the genomic DNA of the cells. This results in the introduction of mutations or deletions that disable the expression of the SLC35E1 gene. Consequently, these cell lines serve as a vital platform for researchers seeking to understand the implications of SLC35E1 in various physiological and pathological contexts, including its involvement in nucleotide sugar transport and potential links to metabolic disorders.
The scientific relevance of SLC35E1 Gene Knockout Cell Lines extends into multiple domains, including cancer research, immunology, and drug discovery. They are particularly valuable for assessing the functionality of the SLC35E1 gene in cellular metabolism or how its dysregulation can contribute to diseases, enabling clinicians to explore novel therapeutic strategies.
Compared to conventional cell lines, these knockout models offer distinct advantages, providing clearer insights into the gene’s role without the confounding effects of gene expression. Furthermore, they can be customized for specific experimental needs, allowing for adaptability across diverse research applications.
For researchers, clinicians, and biotechnology firms, investing in SLC35E1 Gene Knockout Cell Lines represents a significant advantage in the pursuit of cutting-edge biological insights and therapeutic development. Our company specializes in the production of high-quality genetic models, ensuring accuracy and reliability in your scientific inquiries, and we are dedicated to supporting the advancement of molecular biology research through innovative tools like the SLC35E1 knockout models.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.